GLY-200 / Glyscend  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GLY-200 / Glyscend
ACTRN12621000800820p: A Phase 1 Randomized, Placebo-Controlled, Single & Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of GLY-200 in Healthy Adult Subjects

Not yet recruiting
1
64
 
Glyscend Pty Ltd, Glyscend Pty Ltd
Type 2 Diabetes
 
 
ACTRN12621000800820: A Phase 1 Randomized, Placebo-Controlled, Single & Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of GLY-200 in Healthy Adult Subjects

Completed
1
64
 
Glyscend Pty Ltd, Glyscend Pty Ltd
Type 2 Diabetes
 
 

Download Options